These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 17452938)

  • 1. Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to a multiresistant Pseudomonas aeruginosa strain.
    Cirioni O; Ghiselli R; Orlando F; Silvestri C; Mocchegiani F; Rocchi M; Chiodi L; Abbruzzetti A; Saba V; Scalise G; Giacometti A
    Crit Care Med; 2007 Jul; 35(7):1717-23. PubMed ID: 17452938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of the combination of alpha-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection.
    Cirioni O; Silvestri C; Ghiselli R; Orlando F; Riva A; Mocchegiani F; Chiodi L; Castelletti S; Gabrielli E; Saba V; Scalise G; Giacometti A
    J Antimicrob Chemother; 2008 Dec; 62(6):1332-8. PubMed ID: 18799470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic efficacy of buforin II and rifampin in a rat model of Acinetobacter baumannii sepsis.
    Cirioni O; Silvestri C; Ghiselli R; Orlando F; Riva A; Gabrielli E; Mocchegiani F; Cianforlini N; Trombettoni MM; Saba V; Scalise G; Giacometti A
    Crit Care Med; 2009 Apr; 37(4):1403-7. PubMed ID: 19318826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis.
    Cirioni O; Giacometti A; Ghiselli R; Orlando F; Kamysz W; D'Amato G; Mocchegiani F; Lukasiak J; Silvestri C; Saba V; Scalise G
    J Infect Dis; 2004 Jul; 190(2):356-64. PubMed ID: 15216473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of the bovine antimicrobial peptide indolicidin combined with piperacillin/tazobactam in experimental rat models of polymicrobial peritonitis.
    Ghiselli R; Giacometti A; Cirioni O; Mocchegiani F; Orlando F; Silvestri C; Di Matteo F; Abbruzzetti A; Scalise G; Saba V
    Crit Care Med; 2008 Jan; 36(1):240-5. PubMed ID: 18090372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models.
    Giacometti A; Ghiselli R; Cirioni O; Mocchegiani F; D'Amato G; Orlando F; Sisti V; Kamysz W; Silvestri C; Naldoski P; Lukasiak J; Saba V; Scalise G
    J Antimicrob Chemother; 2004 Sep; 54(3):654-60. PubMed ID: 15294887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain.
    Cirioni O; Ghiselli R; Silvestri C; Kamysz W; Orlando F; Mocchegiani F; Di Matteo F; Riva A; Lukasiak J; Scalise G; Saba V; Giacometti A
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2005-10. PubMed ID: 17403995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand.
    Koomanachai P; Tiengrim S; Kiratisin P; Thamlikitkul V
    Int J Infect Dis; 2007 Sep; 11(5):402-6. PubMed ID: 17291803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa.
    Aoki N; Tateda K; Kikuchi Y; Kimura S; Miyazaki C; Ishii Y; Tanabe Y; Gejyo F; Yamaguchi K
    J Antimicrob Chemother; 2009 Mar; 63(3):534-42. PubMed ID: 19147523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colistin offers prolonged survival in experimental infection by multidrug-resistant Acinetobacter baumannii: the significance of co-administration of rifampicin.
    Pantopoulou A; Giamarellos-Bourboulis EJ; Raftogannis M; Tsaganos T; Dontas I; Koutoukas P; Baziaka F; Giamarellou H; Perrea D
    Int J Antimicrob Agents; 2007 Jan; 29(1):51-5. PubMed ID: 17189095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and microbiological efficacy of colistin therapy in combination with rifampin and imipenem in multidrug-resistant Pseudomonas aeruginosa diabetic foot infection with osteomyelitis.
    Tascini C; Menichetti F; Gemignani G; Palumbo F; Leonildi A; Tedeschi A; Piaggesi A
    Int J Low Extrem Wounds; 2006 Sep; 5(3):213-6. PubMed ID: 16928678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Returning to the pre-antibiotic era in the critically ill: the XDR problem.
    Paterson DL; Lipman J
    Crit Care Med; 2007 Jul; 35(7):1789-91. PubMed ID: 17581370
    [No Abstract]   [Full Text] [Related]  

  • 13. Microbiological activity and clinical efficacy of a colistin and rifampin combination in multidrug-resistant Pseudomonas aeruginosa infections.
    Tascini C; Gemignani G; Ferranti S; Tagliaferri E; Leonildi A; Lucarini A; Menichetti F
    J Chemother; 2004 Jun; 16(3):282-7. PubMed ID: 15330326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro activities of colistin combinations against Pseudomonas aeruginosa isolated from the intensive care unit].
    López-Fabal F; Culebras E; Bonilla I; Gómez M; Picazo JJ
    Rev Esp Quimioter; 2008 Sep; 21(3):189-93. PubMed ID: 18792821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock.
    Giacometti A; Cirioni O; Ghiselli R; Orlando F; Kamysz W; Rocchi M; D'Amato G; Mocchegiani F; Silvestri C; Łukasiak J; Saba V; Scalise G
    Peptides; 2005 Feb; 26(2):207-16. PubMed ID: 15629532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of the amphibian peptide distinctin in a neutropenic mouse model of staphylococcal sepsis.
    Cirioni O; Ghiselli R; Orlando F; Silvestri C; De Luca S; Salzano AM; Mocchegiani F; Saba V; Scalise G; Scaloni A; Giacometti A
    Crit Care Med; 2008 Sep; 36(9):2629-33. PubMed ID: 18679116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-thanatin in vitro prevents colistin resistance and improves its efficacy in an animal model of Pseudomonas aeruginosa sepsis.
    Cirioni O; Wu G; Li L; Orlando F; Silvestri C; Ghiselli R; Shen Z; Gabrielli E; Brescini L; Lezoche G; Provinciali M; Guerrieri M; Giacometti A
    Peptides; 2011 Apr; 32(4):697-701. PubMed ID: 21262298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial efficacy of inhaled squalamine in a rat model of chronic Pseudomonas aeruginosa pneumonia.
    Hraiech S; Brégeon F; Brunel JM; Rolain JM; Lepidi H; Andrieu V; Raoult D; Papazian L; Roch A
    J Antimicrob Chemother; 2012 Oct; 67(10):2452-8. PubMed ID: 22744759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy.
    Garnacho-Montero J; Sa-Borges M; Sole-Violan J; Barcenilla F; Escoresca-Ortega A; Ochoa M; Cayuela A; Rello J
    Crit Care Med; 2007 Aug; 35(8):1888-95. PubMed ID: 17581492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis.
    Ghiselli R; Giacometti A; Cirioni O; Dell'Acqua G; Bergnach C; Orlando F; Mocchegiani F; Silvestri C; Skerlavaj B; Licci A; Balaban N; Zanetti M; Scalise G; Saba V
    Shock; 2006 Sep; 26(3):296-301. PubMed ID: 16912656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.